Monoclonal antibodies against HER2 epitope and methods of use thereof

Antibodies Against Human NKG2D and Uses Thereof

Anti PD-L1 antibodies

B7-H3 antibody, antigen-binding fragment thereof and medical use thereof

COMPOSITION COMPRISING AVELUMAB

Anti PD-1 antibodies

Anti-KIR3DL1 antibodies

Anti-ILT3 antibodies and antibody drug conjugates

ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP

Monoclonal antibody against both IL-17A and IL-17F and use of the same

IMMUNOGLOBULIN-BINDING PEPTIDE WITH IMPROVED STABILITY

ANTIBODIES RECOGNIZING MEDIN

Method of detecting the presence of complement C5

Anti human annexin A1 antibody

Anti-PCNA monoclonal antibodies and use thereof

Methods to identify immunogens by targeting improbable mutations

Multivalent regulatory T cell modulators

ROR1 Antibody Immunoconjugates

Anti-ICOS agonist antibodies and uses thereof

Mice expressing a limited immunoglobulin light chain repertoire

ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING

Anti-coagulation factor XI antibody

PSMA binding agents and uses thereof

TRISPECIFIC ANTIGEN BINDING PROTEINS

Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptide

Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof

BAFF selective binding compounds and related methods

ANTI-TIM-3 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES

Compositions and Methods for the Treatment of Cancer

Anti-Sortilin antibodies and methods of use thereof

Molecules with specificity for CD79 and CD22

Nucleic acid encoding anti-GM-CSF antibodies

Alpha-synuclein antibodies

FILAMIN B BINDING PROTEINS AND USES THEREOF

Single domain antibodies to Chikungunya virus

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

Interleukin-2 muteins for the expansion of T-regulatory cells

Nucleic acids encoding plasma kallikrein binding proteins

VARIANTS OF CD38 ANTIBODY AND USES THEREOF

Anti-C5a receptor antibodies

Binding molecules that bind CD137 and PD-L1

IL-17 Receptor A antigen binding proteins

Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma

Anti-vista antibodies and fragments

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS

Anti-Tau antibodies and methods of use

TDP-43 specific binding molecules

Human antibodies to influenza hemagglutinin

Human cytomegalovirus neutralizing antibodies and use thereof

Human antibodies to hemolysin A toxin

Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment

Anti-NRP1 antibody screening method

PDL-1 antibody, pharmaceutical composition thereof, and uses thereof

Bispecific binding molecules binding to VEGF and Ang2

Human-derived anti-dipeptide repeats (DPRs) antibody

ANTI-MCAM ANTIBODIES AND ASSOCIATED METHODS OF USE

Binding molecules to CD38 and PD-L1

Anti-CD40 antibody

Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody

C-KIT antibodies

Human anti-CD47 antibodies and uses thereof

ANTIBODIES FOR IL-17C

Anti (FT) antibodies

Trispecific antagonists

Thrombin-binding antibody molecules and uses thereof

ErbB2 antibodies and uses therefore

ANTI-NR10 ANTIBODY AND USE THEREOF

Anti-ALK2 antibody

Antitumor antagonists

Binding molecules specific for FcγRIIA and uses thereof

Monoclonal antibodies to progastrin and their uses

Conjugates comprising a vascular endothelial growth factor (VEGF) antibody and a hyaluronic acid polymer

Antibody neutralizing human respiratory syncytial virus

Synthetic library of specific binding molecules

Complement factor based affinity chromatography

Glycan-interacting compounds and methods of use

Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles

Compositions and methods for rapid production of versatile nanobody repertoires

Methods and compositions for increasing alpha-L-iduronidase activity in the CNS

NOVEL MULTI-SPECIFIC BINDING PROTEINS

THE CONTORSBODY - A SINGLE CHAIN TARGET BINDER

HUMANIZED ANTIBODIES THAT BIND LGR5

Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

Compositions and methods for treating cancer

ANTI-CXCR4 ANTIBODIES

IL-11Rα antibodies

Monoclonal antibodies to human FLT3/FLK2 receptor protein

Bispecific checkpoint inhibitor antibodies

Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof

Antibody against hepatitis B surface antigen and use thereof

Cell/tissue-specific cell-penetrating antibodies

Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer

CONSTRUCTS TARGETING NY-ESO-1 PEPTIDE/MHC COMPLEXES AND USES THEREOF

Oncofetal antigen binding proteins and related compositions and methods

ADAM9-binding molecules, and methods of use thereof

Prion protein antibodies for the treatment of Alzheimer's disease

Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody

ACVR2A-specific antibody and method of treatment of muscle atrophy

Bispecific checkpoint inhibitor antibodies

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

ANTIGEN BINDING CONSTRUCTS TO CD8

T cell recruiting polypeptides based on CD3 reactivity

Compositions comprising antigen-binding molecules

ANTIGEN BINDING PROTEINS

Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

ANTI-PVRIG/ANTI-TIGIT BISPECIFIC ANTIBODIES AND METHODS OF USE

Anti-IL-27 antibodies and uses thereof

Agents, uses and methods for the treatment of synucleinopathy

Anti-C5 antibodies and methods of treating complement-related diseases

Anti-N3pGlu amyloid beta peptide antibodies and uses thereof

Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)

Anti-HtrA1 antibodies and methods of use thereof

MUC16 specific chimeric antigen receptors and uses thereof

Multi-specific binding proteins for cancer treatment

BINDING AGENTS

Antibodies and polypeptides directed against CD127

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

TIM-3 antibody, antigen binding fragment thereof, and medicinal uses thereof

PROTEINS BINDING BCMA, NKG2D AND CD16

Nucleic acids encoding GARP-TGF-beta 1 antibodies

Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use

Tau-binding antibodies

Antibodies that neutralize botulinum neurotoxins

GLYCOSYLATED TRANSFERRIN RECEPTOR 1 TUMOR ANTIGEN

Car t-cells comprising inactivated CBL and CBL-B genes

Antibodies recognizing genetic variants of NT-proBNP

Anti-tryptase antibodies, compositions thereof, and uses thereof

Anti-MSR1 antibodies and methods of use thereof

Monoclonal antibody directed to FGFR1

Anti-PD-L1 antibody and application thereof

Anti-PD-1 antibodies and compositions

Antibody specifically binding to PD-1 and functional fragment thereof

ANTI-PD-1 SCFVS

Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonist

MONOMERIC HUMAN IGG1 FC AND BISPECIFIC ANTIBODIES

NKp46 binding agents

Inhibition of platelet aggregation using anti-human GPVI antibodies

Anti-podocalyxin antibodies and methods of using the same

Bispecific signaling agents and uses thereof

Amino acid sequence presenting fusion polypeptide and its use

Immunoglobulin single variable domain (ISVD) capable of binding to serum albumin

Serum albumin binders

Serum albumin binding immunoglobulin single variable domains

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Anti-Abeta antibodies and uses thereof

Anti-Tau antibodies and methods of use

Anti-tau antibodies and methods of use

Immunoglobulins and uses thereof

Chemoenzymatic glycoengineering of antibodies and FC fragments thereof

Human endothelin receptor antibody and use thereof

Anti-VLA-4 antibodies

Methods for making and using anti-myostatin antibodies

Catheter package including catheter straightening means

Methods of increasing muscle mass by administration of activin type 2 receptor antibodies

Intrabodies targeting post-translational modifications of native proteins and method for obtaining them

CHIMERIC RECEPTORS, BIOSENSOR HOST CELLS AND METHODS/USES THEREOF

Bispecific HER2 and CD3 binding molecules

Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof

BCMA-targeting antibody and use thereof

ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS

Antibody targeting IL-13RA2 and use thereof

ST2 antigen binding proteins

Antigen binding proteins that bind c-Met

Activatable anti-CTLA-4 antibodies and uses thereof

Anti-SIRPA antibodies and methods of use thereof

Interferon alpha and omega antibody antagonists

Target tissue-specific antigen-binding molecule

Biomarkers for anti-IL4-IL13 bispecific antibodies

IL-31 dog pruritus model

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Red blood cell targeted factor VIII and method of using the same

Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same

Bivalent antibodies masked by coiled coils

PLAZOMICIN ANTIBODIES AND METHODS OF USE

Monoclonal antibodies specific to the plexin-semaphorin-integrin (PSI) domain of RON for drug delivery and its application in cancer therapy

Anti-CD73 antibodies and methods of use thereof

Anti-CD26 antibodies

Anti-CD137 antibodies and uses thereof

Anti-OPG antibodies

Anti-BCMA heavy chain-only antibodies

Anti-CD137 antibodies and uses thereof

Nucleic acids encoding anti-OX40 antibodies

Humanized anti-AXL antibodies

Clec9A binding agents

Antibodies directed against ICOS and uses thereof

TREATMENT OF CANCERS USING ANTI-EMP2 ANTIBODY AND PD-1/PDL-1 PATHWAY ANTAGONIST COMBINATION THERAPY

ANTIBODY SPECIFIC FOR CD22 AND METHODS OF USE THEREOF

Bispecific IgG antibodies as T cell engagers

Antibodies against LIF and uses thereof

Anti-sclerostin antibodies and methods of use

HIGHLY POTENT MONOCLONAL ANTIBODIES TO ANGIOGENIC FACTORS

ANTIGEN ASSOCIATED WITH RHEUMATOID ARTHRITIS

Monovalent anti-properdin antibodies and antibody fragments

HEMAGGLUTININ-SPECIFIC ANTIBODIES AND USES THEREOF

Human Antibodies to Middle East Respiratory Syndrome - Coronavirus Spike Protein

ASPARTATE BETA-HYDROXYLASE CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

Tandem diabody for CD16A-directed NK-cell engagement

Folate receptor 1 antibodies and immunoconjugates and uses thereof

Anti-TNF antibodies, compositions, and methods for the treatment of active ankylosing spondylitis

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

HIV binding agents

Broadly-neutralizing anti-HIV antibodies

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Gene therapy constructs and methods of use

Anti-B7-H4 antibody

Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof

Beta klotho-binding proteins

Constructs targeting histone H3 peptide/MHC complexes and uses thereof

Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof

Anti-PD-L1 and IL-2 cytokines

Anti-B7H3 binding compounds and uses thereof

Cell engaging binding molecules

Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer

PD1 and/or LAG3 binders

Therapeutic biologic for treatment of hepatocellular carcinoma

Multi-Specific Molecules

TUMOR TARGETING CONJUGATES AND METHODS OF USE THEREOF

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

Factor XI antibodies and methods of use

Development of new monoclonal antibodies recognizing human prostate-specific membrane antigen (PSMA)

MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND RELATED METHODS AND USES

Engineered antibodies and uses thereof

CD133-binding agents and uses thereof

IFN-gamma-inducible regulatory T cell convertible anti-cancer (IRTCA) antibody and uses thereof

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor

Anti-FGFR3 antibodies and methods using same

CMET monoclonal binding agents, drug conjugates thereof and uses thereof

IGF-1R antibody and its use as addressing vehicle for the treatment of cancer

Anti-human VISTA antibodies and use thereof

Immunotherapy using antibodies that bind Programmed Death 1 (PD-1)

Anti-ICOS antibodies

LAG-3 binding members

PD1 and/or LAG3 binders

PD1 and/or LAG3 binders

Tunable Chimeric Antigen Receptors

ANTI-LAG3 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-LAG3 ANTIBODIES AND METHODS OF MAKING AND USING ANTI-LAG3 ANTIBODIES

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

Antibodies that bind to human anti-Müllerian hormone (AMH) and their uses

Human anti-IL-33 neutralizing monoclonal antibody

Antibody against trimeric TNFα complex

Antibodies specific for hyperphosphorlated tau for the treatment of ocular diseases

Antibodies recognizing tau

Therapeutic antibodies for treatment of neurodegeneration

Antibodies recognizing tau

Chimeric antigen receptors based on alternative signal 1 domains

Antibody-drug conjugates

Ciliary neurotrophic factor receptor ligands and methods of using the same

Decreased adhesivity receptor-targeted nanoparticles for Fn14-positive tumors

Animal models and therapeutic molecules

Immuno-based retargeted endopeptidase activity assays

Therapeutic anti-IgE antibodies and methods and compositions thereof

NOVEL IMMUNOCONJUGATES

Antibodies specific to alpha-enolase and uses thereof

CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

Anti-CD25 antibody agents

Single-domain antibodies to programmed cell death 1 protein (PD-1), encoding nucleic acids and methods of using same

Bispecific antibodies specific for PD1 and TIM3

Treatment of cancers using anti-NKG2A agents

Agonistic antibodies that bind CD40

Anti-Orai1 antibody

BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING

Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF antagonist

Anti-C3 antibodies

Tau immunotherapy

Anti-Psl binding molecules and uses thereof

Biotin derivatives

Antibody drug conjugates for ablating hematopoietic stem cells

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

SPR-based dual-binding assay for the functional analysis of multispecific molecules

THROMBIN ANTIBODY, ANTIGEN-BINDING FRAGMENT AND PHARMACEUTICAL USE THEREOF

Immunoconjugates

Affinity maturated TAG72 specific single chain antibodies

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS

Antigen binding molecules that bind LIGHT

IL3Ralpha antibody conjugates and uses thereof

Anti-MET antibodies and uses thereof

Anti-TIGIT antibodies

Antibodies directed against ICOS and uses thereof

Targeting agent antibody conjugates and uses thereof

Humanized and affinity matured antibodies to FcRH5 and methods of use

Antibody agents specific for human CD19 and uses thereof

Anti-TREM2 antibodies and methods of use thereof

Treatment of disease responsive to modulation of cannabanoid 1(CB1) receptor signaling

Therapeutic DLL4 Binding Proteins

Anti-Interleukin-6 receptor antibodies

Antibodies to IL-15 and uses thereof

Method of treating cancer by administering an antibody that binds transforming growth factor beta (TGF-beta) 1, TGF-beta 2 and TGF-beta 3

Anti-GP73 monoclonal antibodies and methods of obtaining the same

Antibodies recognizing α-synuclein

Anti-complement factor H antibodies

Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy

Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use

Antibodies that bind zika virus envelope protein and uses thereof

Single domain antibodies directed against arachidonate 12-lipoxygenase

Antibody-drug conjugate having cyclic benzylidene acetal linker

Cell engaging binding molecules

Cell engaging binding molecules